Abstract:BACKGROUND:Diabetes mellitus is characterized by loss or dysfunction of insulin-producing β-cells in the pancreas, resulting in failure of blood glucose regulation and devastating secondary complications. Thus, β-cells are currently the prime target for cell-replacement and regenerative therapy. Triggering endogenous repair is a promising strategy to restore β-cell mass and normoglycemia in diabetic patients. Potential strategies include targeting specific β-cell subpopulations to increase proliferation or maturation. Alternatively, transdifferentiation of pancreatic islet cells (e.g. α- or δ-cells), extra-islet cells (acinar and ductal cells), hepatocytes, or intestinal cells into insulin-producing cells might improve glycemic control. To this end, it is crucial to systematically characterize and unravel the transcriptional program of all pancreatic cell types at the molecular level in homeostasis and disease. Furthermore, it is necessary to better determine the underlying mechanisms of β-cell maturation, maintenance, and dysfunction in diabetes, to identify and molecularly profile endocrine subpopulations with regenerative potential, and to translate the findings from mice to man. Recent approaches in single-cell biology started to illuminate heterogeneity and plasticity in the pancreas that might be targeted for β-cell regeneration in diabetic patients.SCOPE OF REVIEW:This review discusses recent literature on single-cell analysis including single-cell RNA sequencing, single-cell mass cytometry, and flow cytometry of pancreatic cell types in the context of mechanisms of endogenous β-cell regeneration. We discuss new findings on the regulation of postnatal β-cell proliferation and maturation. We highlight how single-cell analysis recapitulates described principles of functional β-cell heterogeneity in animal models and adds new knowledge on the extent of β-cell heterogeneity in humans as well as its role in homeostasis and disease. Furthermore, we summarize the findings on cell subpopulations with regenerative potential that might enable the formation of new β-cells in diseased state. Finally, we review new data on the transcriptional program and function of rare pancreatic cell types and their implication in diabetes.MAJOR CONCLUSION:Novel, single-cell technologies offer high molecular resolution of cellular heterogeneity within the pancreas and provide information on processes and factors that govern β-cell homeostasis, proliferation, and maturation. Eventually, these technologies might lead to the characterization of cells with regenerative potential and unravel disease-associated changes in gene expression to identify cellular and molecular targets for therapy.

Traditional and emerging strategies using hepatocytes for pancreatic regenerative medicine

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

Chemical Strategies for Pancreatic Β Cell Differentiation, Reprogramming, and Regeneration

Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation

Pancreatic islet transplantation: current advances and challenges

Recent advances and potential applications of human pluripotent stem cell-derived pancreatic cells

Systematic Single-Cell Analysis Provides New Insights into Heterogeneity and Plasticity of the Pancreas.

Making human pancreatic islet organoids: Progresses on the cell origins, biomaterials and three-dimensional technologies

Scaling Insulin-Producing Cells by Multiple Strategies

Benefits and Hurdles of Pancreatic β-Cell Replacement

Bioengineering and vascularization strategies for islet organoids: advancing toward diabetes therapy

Advances in Encapsulation and Delivery Strategies for Islet Transplantation

Generation of pancreatic β cells for treatment of diabetes: advances and challenges

From stem cells to pancreatic β-cells: strategies, applications, and potential treatments for diabetes

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes

Hydrogel-encapsulated Pancreatic Islet Cells As a Promising Strategy for Diabetic Cell Therapy

Generation of Human Stem Cell-Derived Pancreatic Organoids (POs) for Regenerative Medicine

The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges

Lineage Reprogramming: A Promising Road for Pancreatic β Cell Regeneration.

Islet transplantation for diabetes: current status and future prospects

Generating Insulin-Producing Cells for Diabetic Therapy: Existing Strategies and New Development